Labcorp, ticker symbol LH, recently experienced a downgrade from HSBC, shifting from a "Buy" recommendation to a "Hold" status. Accompanying this change is an updated price target set at $260. This adjustment suggests a more cautious outlook from the financial institution regarding the stock's future growth prospects. Investors are advised to consider this new guidance as they evaluate their positions in Labcorp.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 17 analysts, the average target price for Labcorp Holdings Inc (LH, Financial) is $277.59 with a high estimate of $300.00 and a low estimate of $248.00. The average target implies an upside of 7.15% from the current price of $259.07. More detailed estimate data can be found on the Labcorp Holdings Inc (LH) Forecast page.
Based on the consensus recommendation from 21 brokerage firms, Labcorp Holdings Inc's (LH, Financial) average brokerage recommendation is currently 1.8, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Labcorp Holdings Inc (LH, Financial) in one year is $263.19, suggesting a upside of 1.59% from the current price of $259.07. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Labcorp Holdings Inc (LH) Summary page.
